From January 1, 2024 to March 31, 2024, the company has repurchased 915,000 shares, representing 0.46% for CNY 15.39 million. With this, the company has completed the repurchase of 2,020,000 shares, representing 1.02% for CNY 28.79 million under the buyback announced on August 31, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.58 CNY | +3.82% | +11.20% | -23.63% |
1st Jan change | Capi. | |
---|---|---|
-23.63% | 435M | |
+26.47% | 661B | |
+26.74% | 566B | |
-6.33% | 352B | |
+19.35% | 332B | |
+4.23% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.04% | 145B |
- Stock Market
- Equities
- 002940 Stock
- News Zhejiang AngLiKang Pharmaceutical CO.,LTD.
- Tranche Update on Zhejiang AngLiKang Pharmaceutical CO.,LTD.'s Equity Buyback Plan announced on August 31, 2023.